Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 1/20 | 0.32 |
| ▸ | SLC6A6 | P31641 | 1/20 | 0.32 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.32 |
| ▸ | BLM | P54132 | 1/20 | 0.32 |
| ▸ | APP | P05067 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1015909 | 0.98 | LMNA (0.33) | LMNASLC6A6CYP2C19BLMAPP | |
| SCHEMBL28393677 | 0.96 | LMNA (0.32) | LMNASLC6A6CYP2C19BLMAPP | |
| SCHEMBL1832184 | 0.86 | LMNA (0.38) | LMNASLC6A6CYP2C19BLMAPP | |
| SCHEMBL1938659 | 0.85 | APP (0.38) | LMNASLC6A6CYP2C19BLMAPP | |
| SCHEMBL8105495 | 0.83 | LMNA (0.32) | LMNASLC6A6CYP2C19BLMAPP | |
| SCHEMBL3468811 | 0.82 | — | — | |
| SCHEMBL8300522 | 0.81 | — | — | |
| SCHEMBL917587 | 0.79 | LMNA (0.31) | LMNASLC6A6CYP2C19BLM | |
| SCHEMBL6771126 | 0.78 | — | — | |
| SCHEMBL6554899 | 0.76 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230091109-A1 | OPHTHALMIC COMPOSITION | Sydnexis, Inc. | 2023-03-23 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230091109-A1 | OPHTHALMIC COMPOSITION | MYOC, PDE6H, PDE6C | LMNA 960/4885SLC6A6 932/4885CYP2C19 4564/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.